Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
January-2017 Volume 15 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2017 Volume 15 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice

  • Authors:
    • Yanan Huo
    • Xin Xie
    • Bo Jiang
  • View Affiliations / Copyright

    Affiliations: Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China, Department of Ophthalmology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
    Copyright: © Huo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 139-145
    |
    Published online on: December 5, 2016
       https://doi.org/10.3892/mmr.2016.5984
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate the signaling pathways associated with functional alterations in corneal tissues following the conditional ablation of serum response factor (Srf) in Dstncorn1 mice. The gene expression profiling array GSE49688, which includes 3 samples each from the wild‑type (WT), Dstncorn1 mutant (corn1) and corn1 mice following the conditional ablation of Srf from the corneal epithelium [namely rescued (res)] mouse groups, was downloaded from the Gene Expression Omnibus database. The limma package was used to identify differentially expressed genes (DEGs) among the three mouse groups. DEGs were subsequently analyzed by dynamic comparison, hierarchical clustering and pathway enrichment analysis. Pathway alteration scores were also calculated in order to study the dynamic metergasis of each identified pathway. A total of 788 DEGs were identified between the corn1 and res groups, 1,365 DEGs were identified between the corn1 and WT groups, and 852 DEGs were identified between the res and WT groups. Among these DEGs, 228 genes were differentially expressed across all three groups, and were mainly enriched in signaling pathways involved in the regulation of the actin cytoskeleton, including the cofilin 1 (CFL1), the mitogen‑activated protein kinase (MAPK) signaling pathway and focal adhesion. The dilated cardiomyopathy signaling pathway displayed the highest alteration score, and was enriched with integrin and integrin β‑6 (ITGB6). In conclusion, the actin cytoskeleton regulatory pathway, MAPK and dilated cardiomyopathy signaling pathways, as well as CFL1 and ITGB6 genes, may be regulated by Srf to serve important roles in the progression of corneal disease.

Introduction

Epithelial hyperproliferation, increased angiogenesis and inflammation are biological processes associated with the pathogenesis of corneal disease, and are the primary cause of bilateral blindness worldwide (1,2). In addition, a number of other disease conditions may arise as a result of abnormal epithelial cell proliferation, inflammation and angiogenesis, such as tumorigenesis and chronic inflammatory disorders (3,4). As a result, investigating the molecular mechanisms underlying these conditions is of critical importance.

Dstncorn1 mice are homozygous for a spontaneous null actin depolymerizing factor destrin (DSTN) allele, which results in an increase in serum response factor (Srf) expression. This increase in Srf production may lead to corneal abnormalities, including epithelial hyperproliferation, neovascularization and inflammation in the cornea (5). Based on these characteristics, Dstncorn1 mice often serve as suitable in vivo models for the investigation of corneal diseases (6). Verdoni et al (1) demonstrated that conditional Srf knockout in the corneal epithelium of Dstncorn1 mice rescues epithelial cell hyperproliferation, neovascularization and inflammatory phenotypes. In addition, previous studies have demonstrated that vascular endothelial growth factor receptor 1 (VEGFR1) was downregulated in Dstncorn1 mice (7) and that conditional Srf knockout Dstncorn1 mice displayed increased levels of VEGFR1 (1). The genome-wide screening of differentially expressed genes (DEGs) in the corneas of Dstncorn1 mice has revealed that a large proportion of upregulated DEGs are targets of Srf (8). Additionally, another study by Verdoni et al (9) indicated that the B-cell receptor signaling pathway served an important role in the phenotype of Dstncorn1 mice. Although a considerable number of studies have focused on understanding the molecular mechanisms of the Dstncorn1 phenotype, the development of various abnormalities remains unclear.

Kawakami-Schulz et al (5) identified the gene networks that were affected by the increased expression of Srf in Dstncorn1 mouse corneas. The expression profiling array GSE49688, which was provided by Kawakami-Schulz et al (5), was downloaded for analysis in the present study. The aim of the present study was to identify DEGs and perform signaling pathway analysis among three types of mice included in the GSE49688 array using various bioinformatics tools. The results may provide an important theoretical foundation for understanding the role of Srf in normal and abnormal corneal tissue homeostasis.

Materials and methods

Affymetrix microarray data

Data from the expression profiling array GSE49688 (5) were downloaded from the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/). This dataset is based on the GPL16570 MoGene-2_0-st Affymetrix Mouse Gene 2.0 ST Array [transcript (gene) version] platform (Affymetrix, Inc., Santa Clara, CA, USA). In total, 9 samples are included in the datasets, with 3 samples each from the following groups: i) Wild-type (WT) mice; ii) a Dstncorn1 mutant mouse model of corneal disease; and iii) Dstncorn1 mutant mice following the conditional ablation of Srf from the corneal epithelium [namely the rescued (res) group].

Data preprocessing and differential expression analysis

The expression profiling probes were first annotated through annotation files. Subsequently, gene symbols were identified from annotation files, with the use of editing codes. Next, expression profiling of gene symbols was performed by Z-score normalization, as previously described (10). The linear models for microarray data (limma) version 3.28.17 (11) in R-software package (www.r-project.org) were applied to identify the DEGs among the three mouse groups. The log2-fold change (log2FC) and the false discovery rate (FDR) (12) were calculated. Genes with log2FC>1 and an FDR <0.05 were considered to be DEGs and were used for subsequent analysis.

Dynamic comparison and hierarchical cluster analyses of DEGs

In order to verify that the three mouse groups represented three distinct states and examine their correlation at a molecular level, dynamic comparisons and unsupervised clustering analyses of DEGs were performed for the 9 samples in the GSE49688 array. DEGs between two mouse groups were determined at a time, thus obtaining three DEG groups, namely the corn1 vs. WT, res vs. corn1 and res vs. WT groups. The common DEGs among the three groups were then clustered hierarchically (13) and visualized using the TreeView program (jtreeview.sourceforge.net/) (14), and genes and samples were normalized using the median center method (15). The similarity matrix used the correlation-centered metric (16).

Pathway enrichment analysis

The Kyoto Encyclopedia of Genes and Genomes (KEGG; www.genome.ad.jp/kegg/) (17) knowledge database is a collection of online databases of genomes, enzymatic pathways and biological chemicals. In the present study, KEGG pathway enrichment analysis for the three groups of DEGs was performed. In addition, their association based on function was determined using the Database for Annotation, Visualization and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov) gene classification tool (18). P<0.05 was established as the threshold for the hypergeometric test.

Pathway alteration score

Quantitative scoring was performed for the potential pathways based on genes enriched in the pathway. The Euclidean distance quantitative method was used to calculate the dynamic metergasis of pathways in the corn1 and res phenotypes compared with the WT phenotype (19). The pathway alteration score was calculated using the following formula:

A(P)=log10(1N∑i=1N(Xgens–Ygens)2),

where A(P) is the alteration score of the pathway, N is the number of DEGs, Xgene is the expression value of gene in the corn1 or res phenotypes and Ygene is the expression value of gene in the WT phenotype group. The higher the score, the clearer the alteration degree of pathway from WT phenotype.

Results

Identification of DEGs

A pairwise comparison of genes from the WT, corn1 and res sample groups was performed in order to identify the DEGs between groups. As presented in Fig. 1A, a total of 1,365 DEGs were identified between the corn1 and WT sample groups, including 867 upregulated and 498 downregulated DEGs. Between the corn1 and res sample groups, 788 DEGs were identified, including 345 upregulated and 443 downregulated DEGs (Fig. 1B). A total of 852 DEGs were identified between the res and WT sample groups, including 593 upregulated and 259 downregulated DEGs (Fig. 1C).

Figure 1.

Volcano plots of microarray gene expression data obtained following the comparison of (A) corn1 vs. WT, (B) res vs. corn1 and (C) res vs. WT groups. The y-axis indicates the -log10 of P-values. DEG, differentially expressed gene; WT, wild-type; Dstn, destrin; FC, fold change; corn1, Dstncorn1 mutant mice; res, serum response factor knockout in Dstncorn1 mutant mice.

Dynamic comparison and hierarchical cluster analysis of DEGs

Dynamic comparison analysis of DEGs among sample groups revealed that the number of DEGs between corn1 and WT was the greatest (n=1,365). Among these, 826 genes overlapped with DEGs identified in the res vs. WT group, 763 genes overlapped with DEGs identified in the res vs. corn1 group, whereas only 6 genes were specific to the corn1 vs. WT group (Fig. 2). In addition, 228 common genes were differentially expressed across all three groups (Fig. 2). These results reflected the differences in expression between the three sample groups, with the res phenotype representing the transition state between WT and corn1 groups.

Figure 2.

Venn diagram showing the differentially expressed genes among the res vs. WT, res vs. corn1 and corn1 vs. WT groups. WT, wild-type; Dstn, destrin; corn1, Dstncorn1 mutant mice; res, serum response factor knockout in Dstncorn1 mutant mice.

Hierarchical cluster analysis results are shown in Fig. 3. The cluster analysis demonstrated that the three groups exhibited distinct gene expression patterns, and confirmed that the res phenotype represented a transition state between WT and corn1 groups.

Figure 3.

Hierarchical cluster analysis heat map of overlapping differentially expressed genes among the WT, corn1 and res groups. Red signals indicate increased expression and green signals indicate reduced expression. WT, wild-type; Dstn, destrin; corn1, Dstncorn1 mutant mice; res, serum response factor knockout in Dstncorn1 mutant mice.

KEGG pathway enrichment analysis

The KEGG signaling pathways enriched by the upregulated and downregulated DEGs are shown in Table I. In the corn1 vs. WT and the res vs. WT groups, the upregulated DEGs were mainly enriched in the cytokine-cytokine receptor interaction and cell adhesion molecule signaling pathways, while the downregulated DEGs were mainly enriched in signaling pathways associated with cellular metabolism. Upregulated DEGs in the res vs. corn1 group were enriched in the retinol metabolism pathway, while downregulated DEGs were primarily enriched in the regulation of actin cytoskeleton (cofilin1 (CFL1) and CFL2) and mitogen-activated protein kinase (MAPK) signaling pathways. In addition, the 228 overlapping DEGs among the three groups were mainly enriched in the focal adhesion, MAPK and regulation of actin cytoskeleton signaling pathways.

Table I.

KEGG pathway enrichment analysis showing the identified DEGs among the various mouse groups.

Table I.

KEGG pathway enrichment analysis showing the identified DEGs among the various mouse groups.

KEGG termCountaP-value

A, Upregulated DEGs
Corn1 vs. WT
  mmu04060: Cytokine-cytokine receptor interaction47 9.47×10−17
  mmu04514: CAMs21 3.32×10−5
  mmu04670: Leukocyte transendothelial migration18 3.84×10−5
  mmu04062: Chemokine signaling pathway23 4.15×10−5
  mmu05322: Systemic lupus erythematosus16 8.80×10−5
Res vs. WT
  mmu04060: Cytokine-cytokine receptor interaction41 1.17×10−17
  mmu04640: Hematopoietic cell lineage14 4.05×10−6
  mmu04670: Leukocyte transendothelial migration16 1.00×10−5
  mmu04062: Chemokine signaling pathway19 3.89×10−5
  mmu04514: CAMs17 5.86×10−5
Res vs. corn1
  mmu00830: Retinol metabolism4 4.62×10−2

B, Downregulated DEGs

Corn1 vs. WT
  mmu00830: Retinol metabolism8 1.71×10−4
  mmu00982: Drug metabolism7 1.93×10−3
  mmu00980: Metabolism of xenobiotics by cytochrome P4506 5.85×10−3
  mmu04710: Circadian rhythm3 2.11×10−2
  mmu00071: Fatty acid metabolism4 4.41×10−2
Res vs. WT
  mmu00830: Retinol metabolism5 5.03×10−3
  mmu00982: Drug metabolism5 7.12×10−3
  mmu04710: Circadian rhythm3 7.54×10−3
  mmu00980: Metabolism of xenobiotics by cytochrome P4504 2.99×10−2
Res vs. corn1
  mmu04810: Regulation of actin cytoskeleton16 1.43×10−4
  mmu04510: Focal adhesion13 2.14×10−3
  mmu04010: MAPK signaling pathway14 8.59×10−3
  mmu04270: Vascular smooth muscle contraction8 2.17×10−2
  mmu00052: Galactose metabolism4 2.42×10−2

C, Overlapping DEGs (n=228)

mmu04510: Focal adhesion8 1.64×10−2
mmu04010: MAPK signaling pathway8 2.38×10−2
mmu04810: Regulation of actin cytoskeleton7 3.01×10−2

a Count is the number of DEGs associated with each term. KEGG, Kyoto Encyclopedia of Genes and Genomes; DEG, differentially expressed gene; WT, wild-type; corn1, Dstncorn1 mutant mice; res, serum response factor knockout in Dstncorn1 mutant mice; Dstn, destrin; CAMs, cell adhesion molecules; MAPK, mitogen-activated protein kinase.

Pathway alteration score

The pathway alteration scores of the WT, corn1 and res groups are shown in Fig. 4, and the 10 most altered pathways among the three groups are shown in Table II. Distance scores in Table II indicate the degree of deviation between corn1 or res groups from the WT group that is the absolute difference value between the corn and res scores. WT group served as a reference, and a high score indicated a greater degree of alteration, whereas a low score indicated that corn1 or res group mice were closer to the WT state. The pathways associated with the cardiovascular system, glycometabolism and the inflammatory response exhibited high pathway alteration scores. Of these, the dilated cardiomyopathy signaling pathway demonstrated the greatest score, and was enriched by particular DEGs, including integrin beta 6 (ITGB6).

Figure 4.

Pathway alteration scores in corn1 mice vs. WT, and res vs. WT groups. The dashed-line indicates the degree of deviation between corn1 and WT mice, and the filled-line indicates the degree of deviation between res mice and WT mice. Dstn, destrin; WT, wild-type; MAPK, mitogen-activated protein kinase; corn1, Dstncorn1 mutant mice; res, serum response factor knockout in Dstncorn1 mutant mice.

Table II.

Pathway alteration scores for the deviation of corn1 and res groups from the WT group.

Table II.

Pathway alteration scores for the deviation of corn1 and res groups from the WT group.

PathwayCorn1Res Distancea
Dilated cardiomyopathy−0.1−0.530.43
Vascular smooth muscle contraction−0.32−0.730.41
Fructose and mannose metabolism0.05−0.310.36
Galactose metabolism0.05−0.310.36
MAPK signaling pathway−0.24−0.590.35
Regulation of actin cytoskeleton−0.36−0.670.31
Arachidonic acid metabolism0−0.260.26
Systemic lupus erythematosus−0.57−0.820.25
Fatty acid metabolism0.05−0.20.25
Focal adhesion−0.34−0.580.24

a Distance is the absolute difference value between the corn and res scores, with a higher value indicating a more altered pathway compared with WT. DEG, differentially expressed gene; WT, wild-type; corn1, Dstncorn1 mutant mice; res, serum response factor knockout in Dstncorn1 mutant mice; Dstn, destrin; MAPK, mitogen-activated protein kinase.

Discussion

Srf activation has been reported to be involved in angiogenesis, the maintenance of cell hyperproliferation, inflammation and F-actin accumulation in Dstncorn1 mice (20). Notably, Srf is known to be involved in the pathogenesis of multiple types of cancer, including hepatocellular and colorectal cancer, demonstrating its potential as a disease-causing factor (21,22). In the present study, 228 common genes were differentially expressed in the three groups (WT, corn1 and res), and were mainly enriched in the focal adhesion, MAPK and regulation of actin cytoskeleton signaling pathways. In addition, pathways associated with the cardiovascular system, glycometabolism and the inflammatory response displayed high pathway alteration scores. These results may improve our understanding of the role of Srf in normal and abnormal corneal tissue homeostasis.

In the present study, the actin cytoskeleton pathway was demonstrated to be a significant pathway. In addition, overlapping DEGs in all three groups were enriched for this pathway. The actin cytoskeleton is essential for the maintenance of cell morphology and mechanical support, as well as for the regulation of diverse processes, including apoptosis, cell adhesion, cell migration and phagocytosis (23). Furthermore, the actin cytoskeleton is a critical barrier between the external environment of surrounding cells and the internal cell signaling pathways, which ultimately affects gene expression regulation (5). Ikeda et al (24) suggested that the appropriate regulation of actin dynamics is necessary for the normal maintenance of the corneal epithelium, and aberrant regulation of the actin cytoskeleton leads to epithelial cell proliferation. Notably, Srf is an essential regulator of the actin cytoskeleton, and Srf target genes are known to be regulated by dynamic changes in the actin cytoskeleton (8,25). Thus, mutant Srf-mediated regulation of the actin cytoskeleton pathway may serve an important role in the development of corneal disease in Dstncorn1 mutant mice.

Previous studies have demonstrated that proteins encoded by particular Srf target genes, such as CFL1 and CFL2, serve key roles in actin treadmilling (26,27). In the present study, CFL1 was enriched in the actin cytoskeleton regulatory pathway. CFL1 is a member of the actin depolymerizing factor/CFL family and is a primary regulator of actin dynamics (28). It is ubiquitously expressed and is crucial for efficient actin depolymerization (29). Notably, Ikeda et al (24) demonstrated that CFL1 and DSTN have common functions; however, compensatory mechanisms following functional loss of one actin depolymerizing factor are insufficient to restore normal actin dynamics in the cornea. Therefore, despite observing an upregulation of CFL1 in the res group compared with the corn1 group in the present study, CFL1 may have been unable to completely regulate actin filament dynamics and compensate for the loss of DSTN.

Cell hyperproliferation, angiogenesis and inflammation are biological processes involved in the pathogenesis of corneal disease, as well as in chronic inflammatory disorders and tumorigenesis (3,4). Therefore, it is possible that signaling pathways associated with cancer may be involved in the progression of corneal disease in Dstncorn1 mutant mice. For instance, the MAPK signaling pathway was significant in the current study. Signaling to Srf occurs principally through the MAPK signaling pathway, which stimulates the expression of cell growth-promoting genes that encode proteins responsible for directly activating genes involved in cell cycle progression and growth factors (30,31). Cell cycle regulation is known to be critical for the normal proliferation and development of multicellular organisms (32). The MAPK pathway is frequently activated in human cancer, which can lead to a malignant phenotype through increased cell proliferation (33). In the present study, the MAPK signaling pathway was enriched by particular downregulated DEGs in the res sample group, which indicates that Srf knockout may have affected the function of this pathway. In addition, pathway alteration analysis demonstrated that the dilated cardiomyopathy signaling pathway exhibited the highest score, and ITGB6 was revealed to be enriched in this pathway.

Integrins, consisting of α and β subunits, are a family of cell surface receptors that mediate cell-to-cell adhesion (34,35). Notably, integrins have been reported to contribute to cell proliferation, apoptosis and the regulation of gene expression, and have been suggested to serve important roles in inflammation and tumorigenesis (34,36). In the present study, ITGB6 was observed to be downregulated in the res group compared with the corn1 group, which indicated that ITGB6 may be targeted by Srf. ITGB6 is expressed specifically in epithelial cells (34); thus, epithelial hyperproliferation in the Dstncorn1 mice may be induced by upregulation of ITGB6. Ultimately, the dilated cardiomyopathy signaling pathway and ITGB6 may serve important roles in the process of epithelial hyperproliferation and inflammation in the corneas of Dstncorn1 mice.

In conclusion, the results of the present study provide a comprehensive bioinformatics analysis of DEGs and signaling pathways involved in the dynamic process of Dstncorn1 mice returning to a WT-like state following the conditional ablation of Srf from the corneal epithelium. The actin cytoskeleton, MAPK and dilated cardiomyopathy signaling pathways, as well as CFL1 and ITGB6 DEGs, may be regulated by Srf to serve important roles in corneal disease progression. These results may increase our understanding on the role of Srf in corneal disease tissues. However, further genetic and experimental studies with larger sample sizes are required to confirm the results of the present study, and to identify therapeutic targets for the treatment of corneal diseases.

Acknowledgements

The present study was supported by the National Natural Science Foundation of China (grant no. 81200662), the Zhejiang Provincial Natural Science Foundation of China (grant nos. LY12H12010 and LY13H120002) and the Project of Zhejiang Provincial Department of Health (grant no. 2013KYB141).

References

1 

Verdoni AM, Schuster KJ, Cole BS, Ikeda A, Kao WW and Ikeda S: A pathogenic relationship between a regulator of the actin cytoskeleton and serum response factor. Genetics. 186:147–157. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Li Z, Cui H, Zhang L, Liu P and Bai J: Prevalence of and associated factors for corneal blindness in a rural adult population (the southern Harbin eye study). Curr Eye Res. 34:646–651. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Allavena P, Garlanda C, Borrello MG, Sica A and Mantovani A: Pathways connecting inflammation and cancer. Curr Opin Genet Dev. 18:3–10. 2008. View Article : Google Scholar : PubMed/NCBI

4 

D'Aura Swanson C, Paniagua RT, Lindstrom TM and Robinson WH: Tyrosine kinases as targets for the treatment of rheumatoid arthritis. Nat Rev Rheumatol. 5:317–324. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Kawakami-Schulz SV, Verdoni AM, Sattler SG, Jessen E, Kao WW, Ikeda A and Ikeda S: Serum response factor: Positive and negative regulation of an epithelial gene expression network in the destrin mutant cornea. Physiol Genomics. 46:277–289. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Zhou Q, Li Y and Chen B: The effect of destrin mutations pathways on the gene expression profile. African Journal of Pharmacy and Pharmacology. 6:1746–1752. 2012.

7 

Qazi Y, Wong G, Monson B, Stringham J and Ambati BK: Corneal transparency: Genesis, maintenance and dysfunction. Brain Res Bull. 81:198–210. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Miano JM: SRF'ing the actin cytoskeleton with no destrin. Physiol Genomics. 34:6–8. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Verdoni AM, Aoyama N, Ikeda A and Ikeda S: Effect of destrin mutations on the gene expression profile in vivo. Physiol Genomics. 34:9–21. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Murie C, Barette C, Lafanechère L and Nadon R: Control-Plate Regression (CPR) normalization for high-throughput screens with many active features. J Biomol Screen. 19:661–671. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Diboun I, Wernisch L, Orengo CA and Koltzenburg M: Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI

12 

Jahani M, Nematzadeh G, Dolatabadi B, Hashemi SH and Mohammadi-Nejad G: Identification and validation of functional markers in a global rice collection by association mapping. Genome. 57:355–362. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Petushkova NA, Pyatnitskiy MA, Rudenko VA, Larina OV, Trifonova OP, Kisrieva JS, Samenkova NF, Kuznetsova GP, Karuzina II and Lisitsa AV: Applying of hierarchical clustering to analysis of protein patterns in the human cancer-associated liver. PLOs One. 9:e1039502014. View Article : Google Scholar : PubMed/NCBI

14 

Zhai Y, Tchieu J and Saier MH Jr: A web-based tree view (TV) program for the visualization of phylogenetic trees. J Mol Microbiol Biotechnol. 4:69–70. 2002.PubMed/NCBI

15 

Di Pietro C, Di Pietro V, Emmanuele G, Ferro A, Maugeri T, Modica E, Pigola G, Pulvirenti A, Purrello M, Ragusa M, et al: Anticlustal: Multiple sequence alignment by antipole clustering and linear approximate 1-median computation. Proc IEEE Comput Soc Bioinform Conf. 2:326–336. 2003.PubMed/NCBI

16 

Chen X: Curve-based clustering of time course gene expression data using self-organizing maps. J Bioinform Comput Biol. 7:645–661. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki RA: The DAVID Gene Functional Classification Tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI

19 

Eickhoff SB, Schleicher A, Scheperjans F, Palomero-Gallagher N and Zilles K: Analysis of neurotransmitter receptor distribution patterns in the cerebral cortex. Neuroimage. 34:1317–1330. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Verdoni AM, Schuster KJ, Cole BS, Ikeda A, Kao WW and Ikeda S: Deletion of serum response factor rescues the cornea defects caused by the loss of actin depolymerizing factor (ADF/Destrin) in mouse. Genetics. July 6–2010.(Epub ahead of print). doi: 0.1534/genetics.110.117309.

21 

Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, Yadav A, Nuovo G, Kumar P and Ghoshal K: MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem. 284:32015–32027. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Choi H, Kim KR, Lee JH, Park HS, Jang KY, Chung MJ, Hwang SE, Yu HC and Moon WS: Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/b-catenin complex. Oncol Rep. 21:57–63. 2009.PubMed/NCBI

23 

Dos Remedios C, Chhabra D, Kekic M, Dedova I, Tsubakihara M, Berry D and Nosworthy N: Actin binding proteins: Regulation of cytoskeletal microfilaments. Physiol Rev. 83:433–473. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Ikeda S, Cunningham LA, Boggess D, Hawes N, Hobson CD, Sundberg JP, Naggert JK, Smith RS and Nishina PM: Aberrant actin cytoskeleton leads to accelerated proliferation of corneal epithelial cells in mice deficient for destrin (actin depolymerizing factor). Hum Mol Genet. 12:1029–1036. 2003. View Article : Google Scholar : PubMed/NCBI

25 

Miano JM, Long X and Fujiwara K: Serum response factor: Master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol. 292:C70–C81. 2007.PubMed/NCBI

26 

Kanellos G, Zhou J, Patel H, Ridgway RA, Huels D, Gurniak CB, Sandilands E, Carragher NO, Sansom OJ, Witke W, et al: ADF and Cofilin1 control actin stress fibers, nuclear integrity, and cell survival. Cell Rep. 13:1949–1964. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Maciver SK and Hussey PJ: The ADF/cofilin family: Actin-remodeling proteins. Genome Biol. 3:reviews30072002.PubMed/NCBI

28 

Carlier MF, Laurent V, Santolini J, Melki R, Didry D, Xia GX, Hong Y, Chua NH and Pantaloni D: Actin depolymerizing factor (ADF/cofilin) enhances the rate of filament turnover: Implication in actin-based motility. J Cell Biol. 136:1307–1322. 1997. View Article : Google Scholar : PubMed/NCBI

29 

Ichetovkin I, Grant W and Condeelis J: Cofilin produces newly polymerized actin filaments that are preferred for dendritic nucleation by the Arp2/3 complex. Curr Biol. 12:79–84. 2002. View Article : Google Scholar : PubMed/NCBI

30 

Khachigian LM and Collins T: Inducible expression of Egr-1-dependent genes a paradigm of transcriptional activation in vascular endothelium. Circ Res. 81:457–461. 1997. View Article : Google Scholar : PubMed/NCBI

31 

Gineitis D and Treisman R: Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem. 276:24531–24539. 2001. View Article : Google Scholar : PubMed/NCBI

32 

Zhang W and Liu HT: MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Sumimoto H, Imabayashi F, Iwata T and Kawakami Y: The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J Exp Med. 203:1651–1656. 2006. View Article : Google Scholar : PubMed/NCBI

34 

Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, Nishimura SL, Aldape K, Landers DV, Carpenter W, et al: Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 108:2241–2251. 1995.PubMed/NCBI

35 

Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, Sansoucy BG, Sawyer TK and Languino LR: The integrin-growth factor receptor duet. J Cell Physiol. 213:649–653. 2007. View Article : Google Scholar : PubMed/NCBI

36 

Garlick DS, Li J, Sansoucy B, Wang T, Griffith L, FitzGerald T, Butterfield J, Charbonneau B, Violette SM, Weinreb PH, et al: α(V)β(6) integrin expression is induced in the POET and Pten(pc−/−) mouse models of prostatic inflammation and prostatic adenocarcinoma. Am J Transl Res. 4:165–174. 2012.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Huo Y, Xie X and Jiang B: Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice. Mol Med Rep 15: 139-145, 2017.
APA
Huo, Y., Xie, X., & Jiang, B. (2017). Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice. Molecular Medicine Reports, 15, 139-145. https://doi.org/10.3892/mmr.2016.5984
MLA
Huo, Y., Xie, X., Jiang, B."Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice". Molecular Medicine Reports 15.1 (2017): 139-145.
Chicago
Huo, Y., Xie, X., Jiang, B."Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice". Molecular Medicine Reports 15, no. 1 (2017): 139-145. https://doi.org/10.3892/mmr.2016.5984
Copy and paste a formatted citation
x
Spandidos Publications style
Huo Y, Xie X and Jiang B: Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice. Mol Med Rep 15: 139-145, 2017.
APA
Huo, Y., Xie, X., & Jiang, B. (2017). Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice. Molecular Medicine Reports, 15, 139-145. https://doi.org/10.3892/mmr.2016.5984
MLA
Huo, Y., Xie, X., Jiang, B."Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice". Molecular Medicine Reports 15.1 (2017): 139-145.
Chicago
Huo, Y., Xie, X., Jiang, B."Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice". Molecular Medicine Reports 15, no. 1 (2017): 139-145. https://doi.org/10.3892/mmr.2016.5984
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team